Back to search results

Ondansetron for the Management of Atrial Fibrillation

Abroad (travel likely)RecruitingPHASE4

Conditions

Atrial Fibrillation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Indiana Clinical Research Center, Indianapolis, Indiana, United States

    Contact: Study coordinator (Scott Denne, MD) · sdenne@iupui.edu · 317-274-4920
    Contact: Study coordinator (Sharon Cromer) · scromer2@iupui.edu · 317-278-3446
    Contact: Principal Investigator (James E Tisdale, BSC, PharmD)
    Heather Jaynes, MSN (Sub-investigator)
    Richard J Kovacs, MD (Sub-investigator)
    Fatimah Alhurayri, PharmD, MS (Sub-investigator)

  • Indiana University Health Methodist Hospital, Indianapolis, Indiana, United States

    Contact: Study coordinator (Richard J Kovacs, MD) · rikovacs@iu.edu · 317-274-0907
    Elisabeth von der Lohe, MD (Sub-investigator)
    Ronald Mastouri, MD (Sub-investigator)
    Contact: Principal Investigator (James E Tisdale, PharmD)
    Fatimah Alhurayri, PharmD, MS (Sub-investigator)
    Heather Jaynes, MSN (Sub-investigator)

  • Purdue University, Indianapolis, Indiana, United States

    Contact: Study coordinator (James E Tisdale, BSc, PharmD) · jtisdale@purdue.edu · 317-880-5418
    Contact: Study coordinator (Heather Jaynes, MSN) · hwroblew@iu.edu · 317-847-2094
    Contact: Principal Investigator (James E Tisdale, BSc, PharmD)
    Heather A Jaynes, MSN (Sub-investigator)
    Fatimah Alhurayri, PharmD, MS (Sub-investigator)
Study leads

  • James E Tisdale, PharmD

    Principal Investigator

    Purdue University

View source on ClinicalTrials.gov(opens in a new tab)